Company Name:MorphoSys AG
CEO:

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development.


Key numbers

Market Capitalization:3308463271
Shares Outstanding: 126712496
Float:
Next Earning Date:2020-02-27
TTm EPS: -0.8605
TTm Dividend Rate:
200 days moving average:26.53
50 days moving average: 27.64
One day percent Change: -0.84



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,